Boston Biomedical

Boston Biomedical, Inc. is a company specializing in oncology drug research. Its programs focus on drugs that inhibit multiple carcinogenic pathways, including cancer stemness pathways and modulation of immune responses. The company has developed a range of drugs for the treatment of solid tumors and hematological malignancies.